SCHEMBL9997669

SCHEMBL9997669

CCC(=Cc1cccc(Br)c1)COC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.45
SLC6A19 Q695T7 1/20 0.44
HSD17B3 P37058 1/20 0.42
ALDH1A1 P00352 4/20 0.40
MAPK1 P28482 3/20 0.40
KDM4E B2RXH2 2/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
GAA P10253 2/20 0.39
MAPT P10636 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 2/20 0.38
HTT P42858 1/20 0.38
S1PR4 O95977 1/20 0.38
S1PR1 P21453 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998274 1.00 PKM (0.45) PKMSLC6A19HSD17B3ALDH1A1MAPK1
SCHEMBL9998171 0.89 PKM (0.43) PKMSLC6A19HSD17B3ALDH1A1MAPK1
SCHEMBL9998170 0.89 PKM (0.43) PKMSLC6A19HSD17B3ALDH1A1MAPK1
SCHEMBL9997395 0.84 LMNA (0.41) PKMALDH1A1KDM4EGAAMAPT
SCHEMBL9997393 0.84 LMNA (0.41) PKMALDH1A1KDM4EGAAMAPT
SCHEMBL9998541 0.84 PKM (0.41) PKMSLC6A19HSD17B3ALDH1A1AKR1C3
SCHEMBL9998543 0.84 PKM (0.41) PKMSLC6A19HSD17B3ALDH1A1AKR1C3
SCHEMBL9998153 0.84 PKM (0.48) PKMSLC6A19HSD17B3ALDH1A1MAPK1
SCHEMBL9998151 0.84 PKM (0.48) PKMSLC6A19HSD17B3ALDH1A1MAPK1
SCHEMBL9998367 0.83 MAPT (0.51) ALDH1A1MAPK1AKR1C3AKR1C2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 PKM 1948/4885SLC6A19 1360/4885HSD17B3 454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.